Assistance Listing 93.426
The National Cardiovascular Health Program
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · Centers for Disease Control and Prevention
Assistance Listing 93.426, “The National Cardiovascular Health Program,” is a federal program administered by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. It provides cooperative agreement assistance. GrantsJunction currently tracks 0 open, 0 forecasted and 0 closed opportunities under this listing. The agency reported $76M in obligations for fiscal year 2025.
Program objective
This program supports extensive scientific evidence, links nonmedical factors, including systemic racism and the lack of economic opportunities, with poor health outcomes and increased mortality rates, all of which are preventable. Factors such as poverty, inadequate housing, poor health care, and other debilitating social conditions, commonly referred to as social determinants of health, contribute to long-standing disparities and health inequities. These social conditions contribute to the increased prevalence of cardiovascular disease (CVD) in the US population. CVD is the leading cause of death in the US; stroke is the 5th leading cause. In 2020, about 1 in 5 adults who died from CVD were younger than 65 years old. It is estimated that 1 in 9 health care dollars are spent on CVD. CVD mortality rates declined for several decades due to both clinical and public health interventions, but recently declining death rates from both heart disease and stroke have stalled. One reason is that hypertension, the primary risk factor for CVD, is very common (1 in 2 US adults has hypertension) but control is not. Only 1 in 4 adults with hypertension (26.1%) has it under control. Gains have been made in treating high cholesterol, another primary risk factor for CVD. Overall, the age-adjusted prevalence of high cholesterol decreased from 21% to 10% from 1988–1994 to 2017–2018. This improvement is due in part to individuals’ healthy behaviors such as eating a healthy diet, losing weight, being physically active, and medication adherence, along with clinical contributions from appropriate prescribing and intensification of medication. Additional public health and health system interventions aimed at preventing, detecting, and controlling elevated cholesterol and blood pressure can help to further decrease CVD mortality.
As published in the SAM.gov Assistance Listing.
Current opportunities under 93.426
No open or forecasted opportunities are currently posted under this listing. Programs often post notices on an annual cycle — see recently closed opportunities below for timing.
Eligible applicants (program level)
- U.S. State Government (including the District of Columbia)
State Governments or their Bona Fide Agents (includes the District of Columbia) are eligible
Program-level eligibility from SAM.gov. Each funding notice sets its own requirements.
Reported obligations by fiscal year
Historical data · not a predictionRange and average of financial assistance (from the listing): Average award $1,000,000 Range $850,000 - $2,000,000
Source: SAM.gov Assistance Listing 93.426. Hatched bars are agency estimates. These totals do not indicate approval rates.Frequently asked questions
What is ALN 93.426?
93.426 is the Assistance Listing Number for “The National Cardiovascular Health Program.” Assistance Listing Numbers (formerly CFDA numbers) identify federal assistance programs; individual grant opportunities reference the listing they are funded under.
Who can apply under ALN 93.426?
The SAM.gov listing names these applicant types: U.S. State Government (including the District of Columbia). Each funding notice under the program sets its own eligibility, so check the specific opportunity.
How much funding does 93.426 provide?
The agency reported $75,993,412 in obligations for FY2025 in the SAM.gov Assistance Listing. These are program-wide totals reported by the agency, not a prediction of future awards.